Brain Hemorrhages Open Access Editor-in-Chief: John H. Zhang
Home Brain Hemorrhages All Issues Volume 5 Issue 2
Volume 5 Issue 2, April 2024
PP.53-97
|
8 articles
|
Next Issue
Editorial | Open Access
Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed?
Published: 16 December 2023
2024, 5 (2): 53-54
Research Article | Open Access
Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: The impact of clazosentan and treatment modalities on outcomes
Published: 07 November 2023
2024, 5 (2): 55-61
Research Article | Open Access
Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage
Published: 31 October 2023
2024, 5 (2): 62-68
Research Article | Open Access
Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm
Published: 07 December 2023
2024, 5 (2): 69-73
Research Article | Open Access
Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A case series
Published: 16 October 2023
2024, 5 (2): 74-78
Research Article | Open Access
Initial results of clazosentan with multiple-drug management for the prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
Published: 26 January 2024
2024, 5 (2): 79-84
Research Article | Open Access
A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage
Published: 07 November 2023
2024, 5 (2): 85-90
Review Article | Open Access
Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?
Published: 29 October 2023
2024, 5 (2): 91-97